轻度甲状腺眼病:最常见却研究最少的临床表现
轻度甲状腺眼病是最常见类型但研究最少,其患病率可达全部病例的三分之二,取决于评估者专业水平和诊断标准。多数患者可自发缓解,但部分进展为持续性非活动性TED,现有治疗证据质量低且存在差异。疾病对生活质量和社会心理功能有显著负担,亟需重新审视并开展研究。
要点
- 轻度TED患病率可高达全部TED病例的三分之二,取决于评估者与诊断标准。
- 症状主要源于眼睑改变、软组织受累和眼表疾病,但表现异质。
- 硒补充剂主要在硒不足的活动性轻度TED中研究,对长期非活动性疾病无效。
核心结论
- 轻度TED具有显著的心理社会和功能负担,应以局部、全身或手术方式个体化处理。
- 鉴于对生活质量和社会经济的影响,亟需突出知识空白并开展轻度TED研究。
研究设计与样本
- 本文为综述,总结轻度甲状腺眼病的现有证据。
主要发现
- 轻度TED患病率可达全部病例的三分之二,取决于评估者专业水平和诊断标准。
- 常见症状和体征主要来自眼睑改变、软组织受累和眼表疾病,但表现异质。
- 部分患者中突眼和眼球运动改变可能被当前分类低估。
- 多数轻度TED患者自发缓解,但部分进展,相当比例演变为持续性非活动性TED。
- 现有治疗选择基于稀少、低至中等质量且有时矛盾的证据,导致各国和各专科管理差异显著。
关键数值与推荐
- 硒补充剂主要在硒不足人群的活动性轻度TED中研究,对长期非活动性疾病缺乏疗效。
- 免疫抑制药物和靶向治疗在轻度TED中的适应症和疗效尚不明确。
临床怎么用
- 临床应个体化考虑局部、全身或手术治疗以应对轻度TED的负担。
- 需关注轻度TED对患者生活质量和疾病进展风险的影响。
局限性
- 轻度TED自然史和预防存在不确定性,临床研究资金不足。
- 现有治疗证据质量低至中等且有时矛盾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mild thyroid eye disease (TED) is the most common form of TED, yet it is the least studied. Uncertainties about the natural history and prevention, and underfunding for clinical research, are an obstacle to improving the management of this important group of patients. SUMMARY: The available evidence suggests that the prevalence of mild TED can reach up to two-thirds of all cases, depending on the expertise of the assessor and the criteria used for diagnosis. Prevalent symptoms and signs of mild TED predominantly arise from lid changes, soft tissue involvement and ocular surface disease, but disease presentation is heterogeneous and in some patients proptosis and eye motility changes may be underrated with the current classification. Little is known about the impact of the various manifestations of mild disease on patients' risk of progression and quality of life (QoL). Although in most patients with mild TED the disease remits spontaneously, some patients progress, and a significant proportion evolve to persistent, inactive TED. Current therapeutic options for these patients are based on scarce, low-to-moderate quality and sometimes conflicting evidence, resulting in significant differences in the management of mild TED in different countries and by different specialists. Among the most recommended therapeutic interventions, selenium supplementation was mainly studied in selenium-insufficient populations with active mild TED and it lacks efficacy in longstanding, inactive disease. The use of immunosuppressive drugs and targeted therapies for mild TED are commonly reported by surveys of medical professionals in a clinical setting, but the indication and efficacy of these agents in mild TED remain unclear. CONCLUSIONS: Mild TED has a significant psychosocial and functional burden that should be reconsidered and addressed by local, systemic or surgical treatments in an individualized manner. Given the overall effect on QoL and the socioeconomic impact, it is of immediate importance to highlight the knowledge gaps and the need for research in mild TED.
引用
- Burlacu MC, Bednarczuk T, Lee V, et al. Mild Thyroid Eye Disease-The Most Common yet the Least Studied Presentation of Thyroid Eye Disease. Thyroid. 2026. PMID: 42370743. doi:10.1177/10507256261464556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。